A clinical study carried out in Iran has proven that administration of Kaneka Q10 in patients with reduced sperm motility is effective in improving the kinetic features of sperm.
Most importantly, a follow-up study showed a direct increase in the pregnancy rate.
Iranian professor of Urology Mohammad Reza Safarinejad used a two-way approach to describe the problem in its totality and to cover both of its 'determinants' – ie sperm quality and the corresponding desired outcome, namely the pregnancy rate.
A placebo-controlled randomised clinical trial was used to assess the effects of Kaneka Q10 (a form of Coenzyme Q10) on three semen parameters – sperm density, sperm motility, and sperm morphology.
Study participants were treated for 26 weeks, followed by a 30-week washout period. The trial showed that 300 mg/day Kaneka Q10 significantly improved all three semen parameters, whereas they remained unchanged in the placebo group.
According to a follow-up study, a pregnancy rate of 34.11% was achieved in couples with male factor infertility of unknown cause (idiopathic male factor infertility).
The study even showed a trend towards higher pregnancy rates when the Q10 administration time was extended beyond the 6-months period.
Kaneka Q10 can be used in a wide range of nutraceuticals, as well as in functional foods, either alone or in combination with other substances to create fertility products. Infertility is such a serious problem that people are very open to safe treatments that carry no risk of side-effects but which promise positive outcomes while being low in cost.
Source: Kaneka Q10
- Soho Coffee moves into leisure centre market
- Mocon creates four business units to support global footprint
- Food manufacturers welcome first stage funding success
- Food > Confectionery
- Beverage > Dairy
- Distribution > Retail
- Beverage > Soft Drinks